PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
4.950
-0.110 (-2.17%)
Jul 31, 2026, 4:00 PM EDT - Market closed

PAVmed Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.090.0732.450.380.5
Revenue Growth
-95.73%-97.63%22.14%550.40%-24.60%-
Gross Profit
-0.19-0.15-1.85-3.97-3.24-0.09
Operating Income
-24.4-21.81-44.49-68.8-91.09-54.39
Net Income
-0.060.439.79-66.27-89.26-50.63
Earnings Per Share
-37.37-5.6314.90-274.80-450.90-189.00
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
6.461.541.1919.6439.7477.26
Total Debt
17.0113.3531.8648.7336.640
Net Cash (Debt)
-10.55-11.81-30.68-29.093.1177.26
Net Cash Growth
-----95.98%3264.89%
Net Cash Per Share
-11.11-17.61-45.75-120.6615.70448.50

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-6.25-5.21-33.55-52.04-70.99-40.59
Capital Expenditures
-0.05-0.03-0.06-0.24-1.54-1.47
Free Cash Flow
-6.29-5.24-33.61-52.28-72.53-42.06
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-227.06%-207.04%-61.60%-161.83%-858.62%-17.00%
Operating Margin
-28702.40%-30712.70%-1485.38%-2805.67%-24161.00%-10878.60%
Pretax Margin
-26510.59%-3477.46%949.15%-2785.07%-24116.18%-10878.60%
Profit Margin
-26065.90%-3477.46%949.15%-3232.59%-27384.10%-11225.20%
FCF Margin
-7402.35%-7376.06%-1122.17%-2132.06%-19237.40%-8412.00%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--1.26---
PS Ratio
416.9186.572.3514.41120.33424.93